PT-141

PT-141 (bremelanotide) is a synthetic cyclic heptapeptide researched as a melanocortin-receptor agonist with preferential activity at MC4R — the receptor subtype most closely tied to central regulation of sexual function. It is one of the rare research peptides to complete the full drug-development arc: discovered in a university laboratory, optimized by a biotech company, tested…